R1 RCM — FY2018 Earnings Presentation
13 slides from R1 RCM's earnings presentation, Feb 22, 2019
Slide 1: Fourth Quarter and Full Year 2018 Results Conference Call
Exhibit 99.2 Fourth Quarter and Full Year 2018 Results Conference Call February 22, 2019
Slide 2: Forward-Looking Statements and Non-GAAP Financial Measures
Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute “forward‐looking statements,” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward‐looking statements relate to future, not pa
Slide 3: Q4 and Full Year 2018 Financial Highlights
Q4 and Full Year 2018 Financial Highlights Fourth Quarter Financial Highlights . Revenue of $262.9 million, up $122.6 million and 87.4% compared to the same period last year . GAAP net loss of $5.7 million, compared to GAAP net loss of $40.2 million in the same period last year . Adjusted EBITDA of
Slide 4: 2018 Highlights
2018 Highlights Intermountain Healthcare . New 10‐year Operating Partner agreement announced January 2018 . Demonstrates the value we bring to the table with our deep expertise in the revenue cycle . Plan to open a Technology and Innovation Center in Salt Lake City in Q2 Presence/AMITA Health . Anno
Slide 5: 2019 Priorities
2019 Priorities New business growth . Progression of opportunities in pipeline is encouraging; continues to expand . Strong interest across all go‐to‐market models – Operating Partnership, Co‐Managed and Modular . Remain optimistic in announcing a new end‐to‐end customer by the middle of 2019 Contin
Slide 6: 4Q'18 non-GAAP Results – Q/Q and Y/Y Comparison
4Q’18 non-GAAP Results – Q/Q and Y/Y Comparison ($ in millions) 4Q’18 3Q’18 4Q’17 Key change driver(s) • Q/Q: Contribution from AMG and Revenue $262.9 $250.4 $140.3 Presence/AMITA • Y/Y: New customers and Intermedix • Q/Q: AMG and Presence/AMITA onboarding costs Adjusted Cost of Services $211.3 $206
Slide 7: 2018 vs. 2017 Results (non-GAAP)
2018 vs. 2017 Results (non-GAAP) ($ in millions) 2018 2017 y/y chg. Key change driver(s) • New customers onboarded in last Revenue $868.5 $449.8 93.1% twelve months and Intermedix • New customer onboarding costs Adjusted Cost of Services $731.7 $397.3 84.2% and inclusion of Intermedix • Expansion of
Slide 8: Additional Commentary
Additional Commentary . Net debt of $313.6 million as of 12/31/18, including restricted cash . Expect to start paying down debt with cash from operations or refinance debt in mid‐ 2019 . Net interest expense of $10.7 million in Q4’18 . Interest on subordinated debt paid in cash, did not exercise pay
Slide 9: Financial Outlook
Financial Outlook $m 2019 2020 Revenue 1,150 – 1,250 1,250 – 1,400 GAAP Operating Income 50 – 80 140 – 170 Adjusted EBITDA 145 – 165 235 – 260 $m Contracted Growth1 Contracted Growth1 Revenue 1,150 – 1,200 1,200 – 1,250 1,250 – 1,300 1,300 – 1,400 Adjusted EBITDA 155 – 165 145 – 155 245 – 260 235 –
Slide 10: Appendix
Appendix
Slide 11: Use of Non-GAAP Financial Measures
Use of Non-GAAP Financial Measures . In order to provide a more comprehensive understanding of the information used by R1’s management team in financial and operational decision making, the Company supplements its GAAP consolidated financial statements with certain non-GAAP financial performance mea
Slide 12: Reconciliation of GAAP to non-GAAP Financials
Reconciliation of GAAP to non-GAAP Financials $ in millions Reconciliation of GAAP Net Income (Loss) to non‐GAAP Adjusted EBITDA Reconciliation of GAAP Cost of Services to Non‐GAAP Cost of Services Reconciliation of GAAP Selling, General and Administrative to Non‐GAAP Selling, General and Administra
Slide 13: Reconciliation of GAAP to non-GAAP Financials
Reconciliation of GAAP to non-GAAP Financials $ in millions Reconciliation of GAAP Operating Income Guidance to non‐GAAP Adjusted EBITDA Guidance Net Debt as of 12/31/18 13